UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 161

Sortiert nach

Thromboembolic Events Related to Treatment with Checkpoint Inhibitors: Report of Two Cases

Case reports in oncology, 2018-10, Vol.11 (3), p.648-653

2018

Volltextzugriff (PDF)

Durable Clinical Benefit in Metastatic Renal Cell Carcinoma Patients Who Discontinue PD-1/PD-L1 Therapy for Immune-Related Adverse Events

Cancer immunology research, 2018-04, Vol.6 (4), p.402-408

2018

Volltextzugriff (PDF)

Development of a Multi-Criteria Analysis Decision-Support Tool for the Sustainability of Forest Biomass Heating Projects in Quebec

Sustainability, 2022-10, Vol.14 (20), p.13200

2022

Volltextzugriff (PDF)

The Clinical Presentation, Survival Outcomes, and Management of Patients With Renal Cell Carcinoma and Cardiac Metastasis Without Inferior Vena Cava Involvement: Results From a Pooled Clinical Trial Database and Systematic Review of Reported Cases

Clinical genitourinary cancer, 2018-04, Vol.16 (2), p.e327-e333

2018

Volltextzugriff (PDF)

Disappearing colorectal liver metastases: Strategies for the management of patients achieving a radiographic complete response after systemic chemotherapy

Journal of surgical oncology, 2020-04, Vol.121 (5), p.848-856

2020

Volltextzugriff (PDF)

Low-Dose Bevacizumab Is Effective in Radiation-Induced Necrosis

Case reports in oncology, 2013-12, Vol.6 (3), p.598-601

2013

Volltextzugriff (PDF)

Clinical and demographic profile and quality indicators for heart failure in a rural area

Arquivos brasileiros de cardiologia, 2009-12, Vol.93 (6), p.637-691

2009

Volltextzugriff (PDF)

Epidemiological profile and hospitalization data of patients with inflammatory bowel disease

Journal of Coloproctology, 2020-09, Vol.40 (3), p.209-213

2020

Volltextzugriff (PDF)

Clinical Response to Sorafenib in a Patient with Metastatic Colorectal Cancer and FLT3 Amplification

Case reports in oncology, 2015-02, Vol.8 (1), p.83-87

2015

Volltextzugriff (PDF)

Distance from the anal verge as an indirect measure to predict response to anti-EGFR therapy in left side metastatic colon cancer

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e15153-e15153

2019

Volltextzugriff (PDF)

Next-generation sequencing (NGS) for personalized therapy in metastatic breast cancer: Selection of therapy and outcomes

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e23166-e23166

2017

Volltextzugriff (PDF)

Resistance mechanisms to PD-1 inhibition in melanoma

Translational cancer research, 2016-11, Vol.5 (S6), p.S1123-S1125

2016

Volltextzugriff (PDF)

Meta-analysis of disease free survival (DFS) as a surrogate for overall survival (OS) in localized renal cell carcinoma (RCC)

Journal of clinical oncology, 2017-02, Vol.35 (6_suppl), p.459-459

2017

Volltextzugriff (PDF)

The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell Carcinoma

Cancer immunology research, 2018-07, Vol.6 (7), p.758-765

2018

Volltextzugriff (PDF)

Association of body mass index (BMI) with clinical efficacy of immune checkpoint inhibitors (ICI) in advanced cancer patients: A retrospective analysis

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e15066-e15066

2020

Volltextzugriff (PDF)

Evaluation of disease-free survival as an intermediate metric for overall survival in localized renal cell carcinoma: A trial-level meta-analysis

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.4585-4585

2017

Volltextzugriff (PDF)

Contemporary incidence and epidemiologic trends of brain metastases at renal cell carcinoma diagnosis

Journal of clinical oncology, 2017-02, Vol.35 (6_suppl), p.529-529

2017

Volltextzugriff (PDF)

Next-generation sequencing (NGS) in metastatic breast cancer (mBC) patients: Translation from sequence data into clinical practice

Journal of clinical oncology, 2015-10, Vol.33 (28_suppl), p.133-133

2015

Volltextzugriff (PDF)

Abstract P3-13-09: Personalized therapy in breast cancer: Brazilian experience

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P3-P3-13-09

2015

Volltextzugriff (PDF)

Differential side effects profile in mCRPC patients treated with abiraterone or enzalutamide: A meta-analysis of randomized controlled trials

Journal of clinical oncology, 2016-01, Vol.34 (2_suppl), p.73-73

2016

Volltextzugriff (PDF)

Role of gemcitabine as second-line therapy after progression on FOLFIRINOX in advanced pancreatic cancer: a retrospective analysis

Journal of gastrointestinal oncology, 2015-10, Vol.6 (5), p.511-515

2015

Volltextzugriff (PDF)

Outcomes of PD-1/PD-L1 responders who discontinue therapy for immune-related adverse events (irAEs): Results of a cohort of patients (pts) with metastatic renal cell carcinoma (mRCC)

Journal of clinical oncology, 2017-02, Vol.35 (6_suppl), p.467-467

2017

Volltextzugriff (PDF)

Is neoadjuvant chemotherapy beneficial before radical cystectomy? Examining the external validity of the SWOG-8710 trial

Journal of clinical oncology, 2017-02, Vol.35 (6_suppl), p.331-331

2017

Volltextzugriff (PDF)

Checkpoint inhibitors in metastatic renal cell carcinoma patients including elderly subgroups: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.4580-4580

2017

Volltextzugriff (PDF)

1 – 25 von 161

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(116)
Mit Volltextzugriff
(156)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(76)
Life Sciences & Biomedicine
(52)
Technology
(21)
Humans
(15)
Agriculture
(11)
Female
(11)
Oncology
(11)
Male
(10)
Life Sciences
(9)
Agriculture, Multidisciplinary
(8)
Engineering
(8)
Materials Science
(8)
Microbiology
(8)
Middle Aged
(8)
Adult
(7)
Biomedical And Life Sciences
(6)
Computer Science
(6)
Immunology
(6)
Materials Science, Multidisciplinary
(6)
Science & Technology - Other Topics
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(5)
... seit 30 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Thromboembolic Events Related to Treatment with Checkpoint Inhibitors: Report of Two Cases

Durable Clinical Benefit in Metastatic Renal Cell Carcinoma Patients Who Discontinue PD-1/PD-L1 Therapy for Immune-Related Adverse Events

Development of a Multi-Criteria Analysis Decision-Support Tool for the Sustainability of Forest Biomass Heating Projects in Quebec

The Clinical Presentation, Survival Outcomes, and Management of Patients With Renal Cell Carcinoma and Cardiac Metastasis Without Inferior Vena Cava Involvement: Results From a Pooled Clinical Trial Database and Systematic Review of Reported Cases

Disappearing colorectal liver metastases: Strategies for the management of patients achieving a radiographic complete response after systemic chemotherapy

Low-Dose Bevacizumab Is Effective in Radiation-Induced Necrosis

Clinical and demographic profile and quality indicators for heart failure in a rural area

Epidemiological profile and hospitalization data of patients with inflammatory bowel disease

Palliative Prognostic Index accuracy of survival prediction in an inpatient palliative care service at a Brazilian tertiary hospital

Clinical Response to Sorafenib in a Patient with Metastatic Colorectal Cancer and FLT3 Amplification

Distance from the anal verge as an indirect measure to predict response to anti-EGFR therapy in left side metastatic colon cancer

Next-generation sequencing (NGS) for personalized therapy in metastatic breast cancer: Selection of therapy and outcomes

Resistance mechanisms to PD-1 inhibition in melanoma

Meta-analysis of disease free survival (DFS) as a surrogate for overall survival (OS) in localized renal cell carcinoma (RCC)

The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell Carcinoma

Association of body mass index (BMI) with clinical efficacy of immune checkpoint inhibitors (ICI) in advanced cancer patients: A retrospective analysis

Evaluation of disease-free survival as an intermediate metric for overall survival in localized renal cell carcinoma: A trial-level meta-analysis

Contemporary incidence and epidemiologic trends of brain metastases at renal cell carcinoma diagnosis

Next-generation sequencing (NGS) in metastatic breast cancer (mBC) patients: Translation from sequence data into clinical practice

Abstract P3-13-09: Personalized therapy in breast cancer: Brazilian experience

Differential side effects profile in mCRPC patients treated with abiraterone or enzalutamide: A meta-analysis of randomized controlled trials

Role of gemcitabine as second-line therapy after progression on FOLFIRINOX in advanced pancreatic cancer: a retrospective analysis

Outcomes of PD-1/PD-L1 responders who discontinue therapy for immune-related adverse events (irAEs): Results of a cohort of patients (pts) with metastatic renal cell carcinoma (mRCC)

Is neoadjuvant chemotherapy beneficial before radical cystectomy? Examining the external validity of the SWOG-8710 trial

Checkpoint inhibitors in metastatic renal cell carcinoma patients including elderly subgroups: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC)

Suchergebnisse filtern